avermectin has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Sun, P; Wang, K; Zhang, C; Zhang, Y | 1 |
| Drinyaev, VA; Ermakova, NV; Korystov, YN; Kruglyak, EB; Kublik, LN; Levitman, MKh; Mosin, VA; Novik, TS; Shaposhnikova, VV; Sterlina, TS | 1 |
2 other study(ies) available for avermectin and B16 Melanoma
| Article | Year |
|---|---|
New Avermectin Analogues from a Mutant Streptomyces avermectinius Strain.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Humans; Ivermectin; Melanoma, Experimental; Molecular Structure; Mutation; Spectrum Analysis; Streptomyces | 2017 |
Antitumor effect of avermectins.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Ivermectin; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 2004 |